PBPHPortfolio Building Block World Pharma and Biotech Index ETF

Grow my moneyNewRanked #529 of 2,960 in this goal

Seeks to track the performance of the BITA Global Pharma and Biotech Select Index.

By Portfolio Building Block ETFs · Launched 2025

Annual Cost

0.13%

#636 of 5,562 · low cost

Fund Size

$789M

#1,251 of 5,562 · large

Return (1Y)Goal

N/A

Track Record

7 months

#5,023 of 5,562 · young

Performance

Total-return NAV · USD

Growth of $10,000

$10,191+1.9%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

Global

Cap

Multi cap

Strategy

Index tracking

Sector

Health care

Focus

Biotech & Genomics

Index tracked

BITA Global Pharma and Biotech Select Index

What it actually holds

By weight

Concentration

Top 10 holdings = 60.5% of fundconcentrated

Eli Lilly and CoLLY

15.0%

Johnson & JohnsonJNJ

8.7%

AbbVie IncABBV

6.2%

Merck & Co IncMRK

4.7%

Roche Holding AG Ordinary Shares newROP.SW

4.7%

Novartis AG Registered SharesNOVN.SW

4.6%

AstraZeneca PLCAZN.L

4.4%

Gilead Sciences IncGILD

4.3%

Amgen IncAMGN

4.2%

Pfizer IncPFE

3.8%

Asset allocation

Stocks

99.7%

Cash

0.3%

By sector

Healthcare

100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

N/A

Max drawdown

-11.1%Mild

Worst peak-to-trough loss

Sharpe (3Y)

Unavailable

Needs 3+ years of history

Sortino (3Y)

Not yet

Needs 3+ years of history

Where to buy

Listing

Exchange: NASDAQ Global Select Market

Full fund details

Objective: Seeks to track the performance of the BITA Global Pharma and Biotech Select Index.
Strategy: Uses a passive management approach to track the BITA Global Pharma and Biotech Select Index, which includes companies in the pharmaceutical and biotechnology industries with market caps of at least $10 billion.
Inception date: November 25, 2025
Fund family: Portfolio Building Block ETFs